# Human Chorionic Gonadotrophin & Trigger

> **NCT02264847** · PHASE3 · UNKNOWN · sponsor: **Cairo University** · enrollment: 200 (estimated)

## Conditions studied

- Ovulation Disorder

## Interventions

- **DRUG:** Human chorionic gonadotrophin
- **DRUG:** clomiphene citrate alone

## Key facts

- **NCT ID:** NCT02264847
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2017-04
- **Final completion:** 2017-05
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2017-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02264847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02264847, "Human Chorionic Gonadotrophin & Trigger". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02264847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*